Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema
Hutton, David, Adam Glassman, Danni Liu, Jennifer Sun, and DRCR Retina Network. 2023. “Cost-Effectiveness of Aflibercept Monotherapy Vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema”. JAMA Ophthalmol.